International Journal of Pharma Growth Research Review  |  ISSN: 3049-0421  |  Double-Blind Peer Review  |  Open Access  |  CC BY 4.0

Current Issues
     2026:3/5

International Journal of Pharma Growth Research Review

ISSN: (Print) | 3049-0421 (Online) | Impact Factor: 8.51 | Open Access

Exploring the Therapeutic Potential of Danshen (Salvia miltiorrhiza) and Ginkgo Biloba in Coronary Heart Diseases: A Network Pharmacology Investigation

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF)

Abstract

Traditional Chinese medicine (TCM) pattern is beneficial in complicated diseases such as CHD as a classification method. In the case of atherosclerosis, plaque builds up in the arteries, and can become a serious problem in various parts of the body. In China, Salvia miltiorrhiza and Ginkgo biloba have been employed as medicinal plants in treating some complex diseases such as CVD. But there are mechanisms that need to be explored for the particular treatments. The aim of this study was to use network pharmacology to clarify the molecular mechanism of GDHP in the therapy of CHD. Batman-TCM was used to investigate the targets and bioactive compounds that were part of the GDHP. The pharmaceutical databases were used to extract the targets for CHD disease. Next, the protein-protein interaction (PPI) network was constructed using Cytoscape software and STRING online tool. The DAVID online tool was used to perform the KEGG and GO analysis. Finally, to confirm GDHP's potential targets for CHD treatment, molecular docking of the active components was performed. After screening, 199 matching targets and 34 active compounds were discovered. There were 16 common targets between CHD and GDHP. According to the results obtained from the network analysis, it appears that tanshinone IIA, miltirone, and gallocatechin could be classified as three distinct therapeutic components. There were eight main potential targets according to enrichment analysis the majority of the discovered genes were engaged in CHD-related pathways. This implies that discovered compounds may be the main GDHP active substances for atherosclerosis. In the current experiment, the binding potential of active substances to target sites was determined by conducting the network pharmacology analysis to determine the target sites, mechanism and related signaling pathway of GDHP for the treatment of CHD. This indicates that the new substances obtained from GDHP may become the major drugs to treat atherosclerosis, and this can have a very high connection with inflammatory response, lipid metabolism and fluid shear stress. By conducting the network pharmacology, we give new insights into the possible mechanism of GDHP for the treatment of CHD.

How to Cite This Article

Muhammad Kashif Aslam, Noureen Ashraf, Shawana Ambreen, Sehrish Jehan, Shehnaz Bibi, Abdul Arham, Zunera Iqbal, Minahil Ashraf, Mehwish Yousaf, Nayab Tahir, Farhana, Abeer Ilyas, Aleezah Shaukat ul Hassan (2026). Exploring the Therapeutic Potential of Danshen (Salvia miltiorrhiza) and Ginkgo Biloba in Coronary Heart Diseases: A Network Pharmacology Investigation . International Journal of Pharma Growth Research Review (IJPGARR), 3(6), 01-11. DOI: https://doi.org/10.54660/IJPGRR.2026.3.6.01-11

Share This Article: